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Abstract
Abnormal placentation is a noncommon but life-threatening obstetric condition that 
requires a multidisciplinary approach. It is a spectrum of disorders that seems to parallel 
the increasing rate of cesarean sections. Imaging findings have a crucial role in detecting 
this abnormality early in the pregnancy and subsequently guiding and alerting the sur-
geon. Between accreta and percreta, the difference is huge; thus, they are managed with a 
different degree of radicality. The surgeon tends to treat more radically cases of placenta 
percreta with cesarean hysterectomy and needs to have special expertise in pelvic sur-
gery, inter alia, and gynecologic oncology. While extrapolation does not find its way in 
every case of abnormally invasive placenta, a new inspired technique from gynecologic 
oncology surgeries and adapted to percreta cases seems to be applied safely and effec-
tively in all circumstances of percreta. Conservative treatment is also an alternative but is 
limited to selected cases of placenta accreta.
Keywords: abnormally invasive placenta, cesarean hysterectomy, safety, radical, 
conservative, multidisciplinary
1. Introduction
Placenta accreta, placenta increta, and placenta percreta represent a spectrum of placental 
adhesive disorders (PAD) and occur when a defect of the decidua basalis allows the inva-
sion of chorionic villi into the myometrium. PAD is classified on the basis of the extent of 
adherence to and invasion of the myometrium. Placenta accreta is the least severe of the three 
entities with superficial invasion of the basalis decidua by the chorionic villi (approximately 
75% of cases). Placenta increta is penetration of the myometrium by the chorionic villi, while 
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placenta percreta is the most severe with invasion of uterine serosa or adjacent pelvic organs 
[1, 2]. It is worth noting that when the myometrium becomes very thin especially at the level 
of the cesarean section, difference between accreta and increta is obsolete.
The frequency of abnormal invasive placentation (AIP) has risen in the last 30 years parallel 
to the increase in cesarean delivery rate [3, 4]. Other common risk factors for abnormal pla-
centation include placenta previa, prior myomectomy or other uterine surgery, and advanced 
maternal age [5].
AIP is a life-threatening condition due to massive hemorrhage and urgent need for blood 
transfusion, the need for peripartum hysterectomy, damage to adjacent organs due to placen-
tal invasion, and the need for admission to the intensive-care unit [4, 6, 7]. For these reasons 
and their consequence of decreasing the burden of maternal morbidity-mortality, it is essen-
tial to accurately diagnose the degree of placental invasion. The major predicting determinant 
of the outcome of women affected of AIP is the depth of placental invasion [3].
2. Imaging findings
Imaging in the antepartum should be performed with minimal risk to both the mother and 
developing fetus. Noninvasive techniques such as ultrasound (US) and magnetic resonance 
imaging (MRI) that do not use ionizing radiation are thus the preferred imaging techniques. 
The advantages of MRI are superior soft-tissue contrast resolution, multiplanar imaging 
capabilities, wider field of view, and image quality independent of the mother’s size or fetus 
positioning. Thus, it may be superior to US in some settings [1, 2].
However, US remains the primary method of imaging the placenta. Also, its high negative 
predictive value for placental abnormalities assigns MRI to a supporting role reserved for 
equivocal US findings or incomplete evaluation as in cases of posterior placenta [5].
2.1. Ultrasound
Ultrasonography is the primary screening tool for placental invasion in women at high risk 
of AIP usually performed during the second and third trimesters of pregnancy [8–10]. Its 
sensitivity for the diagnosis of AIP ranges from 77 to 93% and specificity from 71 to 97% 
according to a recent review [6, 8, 11], but its sensitivity and specificity may increase to 100% 
when applied to a high-risk population [3].
Many US signs are described for the diagnosis of abnormal placental invasion. These signs 
include the following [3, 8, 9]:
1. Loss or irregularity of the hypoechoic plane in myometrium underneath placental bed 
(“the clear zone”) or retroplacental myometrial thinning <1 mm
2. Multiple placental lacunae, often containing turbulent flow visible on grayscale or color 
Doppler US
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3. Bladder wall loss or interruption or irregularity (loss of hyperechoic band or “line” between 
uterine serosa and bladder lumen)
4. Uterovesical hypervascularity, defined as striking color Doppler signal observed between 
myometrium and posterior wall of bladder, including vessels bridging uterine-placental 
margin, across myometrium and beyond serosa into the bladder or other organs; running 
perpendicular to the myometrium
5. Invasion of the cervix, resulting in abnormal cervical shape, cervical lacunae, and placenta 
previa
6. Vascular invasion of the parametria, defined as the presence of hypervascularity extending 
beyond the lateral uterine walls and involving the region of the parametria
In addition, we should emphasize on the US limitations especially regarding the difficult 
access to posterior placental locations, the evaluation of the degree of placental infiltration, or 
the presence of associated myometrial lesions [4, 10, 12, 13].
2.2. Magnetic resonance imaging (MRI)
MRI is a secondary diagnostic tool for AIP and indicated when US is limited and inconclusive 
or in cases of a posterior placenta [4, 6, 7, 10, 14]. The examination typically is made between 
24 and 32 weeks of gestational age, in a supine position, but if not tolerated it can be made 
in left lateral decubitus or oblique position. The bladder is partially distended during the 
study. MRI protocol is essentially based on three-plane T2 sequences for the placental assess-
ment (single-shot T2-weighted fast spin echo sequences or T2-weighted TSE); a T1-weighted 
sequence can be acquired, and recently, the utility of diffusion-weighted imaging is discussed 
in many studies [6]. Although contrast-enhanced imaging can improve the diagnostic accu-
racy of placental invasion while improving the contrast between the myometrium and the 
placenta, gadolinium usage during pregnancy should be avoided [6, 7]. MRI signs suggesting 
AIP include the following [4, 6, 10, 15]:
1. Myometrial thinning or focal interruption of the myometrium by placenta
2. Presence of dark intraplacental bands on T2-weighted imaging running perpendicular to 
the myometrium
3. Tenting of the bladder
4. Uterine bulging defined as a focal outward contour or a loss of the pear shape of the uterus
5. Direct visualization of focal exophytic mass breaking through uterine serosa and invading 
pelvic structures
6. Heterogeneous intraplacental signal intensity but can be a subjective sign depending on 
the gestational age of the placenta
7. Abnormal intraplacental vascularity (Figure 1A-D)
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3. Surgical management
Identifying a PAD preoperatively will give the surgeon the chance to plan and modify the 
surgical technique in order to reduce morbidity [16]. In addition, a prenatal diagnosis or sus-
picion of placenta percreta can alert the obstetrician in charge to the need for an experienced 
pelvic surgeon in critical cases. A preoperative preparation is essential in accreta cases and 
requires multidisciplinary efforts. It is mandatory to involve all specialized peers in the pre-
operative assessment as well as in operative management: obstetrics anesthesiologist, gyne-
cologic oncologist, urologist, vascular surgeon, and interventional radiologist [16]. This was 
also emphasized on in the Committee Opinion 29, where the American College of Obstetrics 
and Gynecologists (ACOG) has advocated the involvement of a multidisciplinary team in the 
Figure 1. A 26-week-old fetus with placenta praevia showing: A. An increased vascularity seen in the lower uterine 
segment and the interface with the bladder seen on a sagittal image on US. B. On 1.5 MRI, sagittal sequence T2WI: 
a heterogeneity in the placenta (arrow) overlying the internal os (double arrows) with involvement of surrounding 
structures and focal myometrial interruption with extension into the bladder wall (C, arrowhead). D. On axial sequence 
T2WI: a heterogeneity in the placenta with dark intraplacental bands (double arrowheads). This was consistent with 
percreta on surgery and histopathology.
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management of morbid placental adherence to minimize potential maternal or neonatal mor-
bidity and mortality [17]. Coordination with the blood bank before beginning the procedure 
is essential to ensure adequate supplies of red cells, platelets, and fresh frozen plasma [16]. In 
their study, Brennan et al. have also specified that the early presence of a gynecologic oncolo-
gist at delivery is a key predictor of reduced blood loss and transfusion requirements when 
abnormally invasive placenta is suspected [18]. Furthermore, other authors have reported 
that outcomes are improved if delivery takes place in centers with multidisciplinary expertise 
and experience in PAS disorders [19].
Cesarean hysterectomy in cases of placenta percreta is often technically challenging due to the 
anatomic and physiologic changes of pregnancy, including a massive increase in blood flow 
to the uterus at term. The vessels that supply the uterus, ovaries, and bladder are substantially 
larger and more tortuous in pregnancy than they are in the nonpregnant state. Meticulous 
care in the manipulation of clamps, cutting of pedicles, and placement of sutures is required 
to prevent severe bleeding. Scarring from previous surgery, particularly previous cesarean 
sections, is a common complicating feature of cesarean hysterectomy [20]. These cesarean 
hysterectomies often require difficult dissection of poorly defined tissue planes, particularly 
of the bladder interface, and partial bladder resection is often required [21]. All these fac-
tors make this procedure associated with a higher risk of complications in comparison with 
abdominal hysterectomies performed for benign indications [22].
3.1. Surgical technique
In the literature, few reports of a well-standardized technique describe the steps of a cesar-
ean hysterectomy among women with placenta percreta who need radical treatment. When 
performing such a procedure, the major concern is to prevent ureteral lesions in a pelvis with 
a distorted anatomy and to reduce blood loss. A recent study has demonstrated the effective-
ness and safety of a well-standardized approach for managing all cases of placenta percreta 
and in all circumstances [23].
It is preferable to schedule cesarean hysterectomy in case of placenta percreta starting at 34 weeks 
of gestational age. However, cesarean is sometimes carried out as an emergency procedure irre-
spective of gestational age in cases of heavy bleeding or fetal distress.
The technique that we intend to describe was developed based on collected experience in 
gynecologic oncology. First of all, the placement of ureteral stents is not necessary according 
to this technique since it is not always possible especially during emergencies in cases with 
massive bleeding [24]. The surgeon starts with a vertical midline incision under general anes-
thesia. A peroperative US is performed to localize the placenta and to guide the surgeon while 
performing the hysterotomy. After delivery of the baby, the surgeon proceeds with a closure 
of the uterine incision with Vicryl® “0” hepatic needle sutures (Ethicon, Johnson and Johnson 
Companies, Somerville, NJ, USA). In a next step, the surgeon approaches the retroperitoneum 
just lateral to the adnexal ligaments to secure the ureters and to clip the uterine arteries at 
their origin after opening the paravesical space. The uteroadnexal ligaments also need to be 
ligated as close as possible to the uterus. After clipping the uterine arteries, these are lifted up 
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Figure 3. In this case, dissection was impossible so partial cystectomy was performed.
to expose the underlying uterine veins, which are also clipped. This is followed by a freeing of 
the ureters from their crossing with the uterine arteries. A crucial following step is to dissect 
the rectovaginal space and to perform a posterior vaginal incision aided with a flat retractor 
in the posterior vaginal fornix (Figure 2). This will aid the subsequent lifting of the uterus 
through this posterior incision. The bladder is filled to identify the right plane, and then it 
is cautiously dissected and separated. After exposing the bladder-vaginal interface, an ante-
rior vaginal incision is done aided by placing the vaginal retractor in the anterior cul-de-sac. 
Subsequently, the surgeon will be able to position his index and middle fingers through both 
anterior and posterior incisions, to lift the uterus and to place the clamps alongside the cervix 
after making sure that ureters are at distance. In case of severe adherence or bladder invasion, 
a cystotomy or partial bladder resection might be needed [23, 24], (Figures 3 and 4). Of note, 
this procedure should not be performed by any surgeon; only a surgeon with appropriate 
expertise in pelvic surgery should operate on these critical cases [25]. Otherwise, the operating 
surgeon will be compromising the safety of the patient.
Figure 2. After filling the bladder helping its separation and dissection, incision of the anterior vagina is done right on 
the inserted fingers.
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On a similar note, the absence of ureteral injuries is guaranteed when performing a cesarean 
hysterectomy according to the aforementioned steps [23]. To prevent the development of 
vesicovaginal fistulas, an omentoplasty is recommended after bladder reparation [23].
Another technique was described in the literature based on a posterior approach but was 
criticized for the ligature of the anterior division of the internal iliac artery with the concomi-
tant risk of bladder devascularization [23, 26]. Also, the fact of grasping a gravid cervix, as 
described in the latter technique, will lead to massive bleeding and is not always feasible in 
case of cervical effacement. However, positioning the surgeon’s fingers through anterior and 
posterior vaginal incision will prevent hazardous bleeding as well as cervical tears.
4. Conservative management
While a radical treatment in terms of cesarean hysterectomy is often the standard of care in 
case of abnormally invasive placenta, conservative treatment may be applied in limited cases 
and when women wish to conserve fertility. This is to mention that conservative management 
is not an approach that fits all cases. Actually, such an alternative can be attempted in cases of 
placenta accreta or increta where the placenta is adhering partially or totally to the myome-
trium without invading the whole uterine wall.
Conservative management consist of two options: (1) to attempt prudent delivery of the pla-
centa, applying moderate cord traction to reduce the risk of leaving a normal placenta in 
situ, or (2) to leave the entire placenta in situ for resorption or spontaneous delivery hoping 
to reduce the risk of subsequent hemorrhage by making no attempt to remove the placenta 
[27]. First of all, placental separation can only be attempted when obstetricians are well 
Figure 4. The specimen of hysterectomy with placenta percreta anteriorly is on the left side. A more close view on the 
right side allows to see the vesical patch that was resected in a case of placenta percreta invading the bladder.
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experienced. They need to be able to identify whether placental separation can be attempted 
in an individual and to perform hysterectomy immediately after failure of placental separa-
tion to rescue the patient [28]. According to ACOG committee’s opinion, placental separation 
by gentle external uterine massage is reasonable in selected women in whom no obvious signs 
of placenta accreta are seen based on the visual examination of the uterus [29]. Furthermore, 
placenta separation can be attempted in three situations: (1) the surgeon is unconfident with 
the preoperative diagnosis of abnormally invasive placenta, (2) the intraoperative US does not 
confirm the diagnosis, and (3) the aberrant vessels are less severe than expected [28].
Second, the entire placenta can be left in situ with or without postoperative administration 
of methotrexate and the placental expulsion will be expected after that. These patients might 
be subject to severe bleeding that may require emergent uterine embolization. This approach 
seems to be associated with severe long-term complications. According to a review of 119 
women who had placenta left in situ, 61% (22 out of 36 cases) had complications occurring 
later than 24 hours postoperatively, compared with 12% of those who initially had a hyster-
ectomy or local resection. The most frequently reported complications in these cases were 
secondary hysterectomy (58%, 21 out of 36 cases) and postoperative hemorrhage (44%, 16 out 
of 36 cases) [30].
5. Recommendations and future directions
The path to a reduced morbidity and mortality in women with AIP starts with an accurate 
antenatal diagnosis. However, we are not yet able to define specific US sign or set of signs 
when assessing the depth of placental malformation [31, 32]. Although many efforts were 
made to standardize the imaging description of PAD [33, 34], more prospective studies are 
needed to study the correlation between antenatal imaging findings and histopathology [35].
When suspecting a PAD prenatally, it is mandatory to refer the patient to a center of excel-
lence with a dedicated multidisciplinary team and care plan [36]. Although the described 
techniques in the literature have shown satisfactory results in terms of safety and effective-
ness, the reproducibility of the results might be improved by an analysis and an application 
of these techniques on larger case series in the future.
Obstetricians and gynecologists need to be counseled and advised about the indications and 
the situations where a conservative approach could be attempted. Case-control studies on 
large populations should be conducted to help the surgeon in making the decision when 
tending to a conservative management.
6. Conclusion
In front of such an individualized problem, a surgeon managing a case of abnormally inva-
sive placenta should be well experienced to master this challenge but also to win it with less 
maternal and neonatal morbidity and mortality. While concrete standards still lack in terms 
of management, there are evidences that accreta and percreta are different. This difference 
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is very important in selecting the strategy and in involving a multidisciplinary team when 
dealing with these critical situations. Gynecologic oncology has added a lot of value to the 
surgical techniques applied in cesarean hysterectomy and adapted to percreta cases. Also, 
we should not also underestimate the important role of the radiologist in suspecting early the 
diagnosis, alerting the surgeon, and subsequently inducing a cascade of preoperative prepa-
ration (Figure 5).
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Figure 5. Schematic steps to be followed in the management of an abnormal invasive placentation (AIP).
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